The effect of betadine drop in neonatal conjunctivitis

The effect of 2.5% betadine in the prevention of neonatal conjunctivitis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017022032680N1

Enrollment

200

Registered

2017-08-13

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Conjunctivitis. Neonatal conjunctivitis and dacryocystitis

Interventions

Intervention 1: In the second group (control) two drops of distilled sterile water will be shed in the conjunctiva eyes. Intervention 2: In the first group (Intervention), two drops of Betadine 2.5%

Prevention

In the second group (control) two drops of distilled sterile water will be shed in the conjunctiva eyes

In the first group (Intervention), two drops of Betadine 2.5% will be shed in the conjunctiva eyes

Eligibility

Sex/Gender

All

Age

No minimum to 3 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: All healthy term and preterm neonates Exclusion criteria: All neonates that needs to resuscitation; special measures; neonates with congenital malformations of the eyes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Conjunctivitis. Timepoint: 22 May 2017-23 June 2017. Method of measurement: Visual.	—

Secondary

Measure	Time frame
Drug sensitivity. Timepoint: 48 hours and one week after treatment. Method of measurement: Visual.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFakhrosadat Hosseini Moghaddam Emami

Qazvin University of Medical Sciences

f.emami@qums.ac.ir+98 28 3333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026